ILiAD Biotechnologies Announces Upcoming Presentation at the European Society for Paediatric Infectious Diseases 2020 Virtual Meeting

NEXT STORY
Corbus Pharmaceuticals Announces Three Lenabasum Abstracts to be Presented at ACR Convergence 2020
PREV STORY
Primo Nutraceuticals Inc. signs a Memorandum of Understanding for Exclusive Rights to Sell Rapid (Colloidal Gold Method) COVID-19 Test Kits in Canada
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioTelemetry, Inc. Announces Extension of the Tender Offer Period for LifeWatch AG Shares

MALVERN, Pa., May 23, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless ...

author_avatar
NASDAQ Market News

Foamix Announces Positive Top-Line Results From Phase II Study for FDX104 (Doxycycline Foam) in the Prevention of Acneiform Rash Associated With Targeted Antibody Treatments for Colon and Head and Neck Cancers

FDX104 prevented the development of moderate-to-severe antibody-induced rash in the majority of cases. FDX104 ...

author_avatar
NASDAQ Market News

EDAP Hosting Key Opinion Leader Call on Focal One® and ExactVu™

author_avatar
NASDAQ Market News